Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2389.49%
operating margin TTM
-2979.12%
revenue TTM
1.10 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | 0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 10.18 |
| enterprise value multiple | -0.72 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | -648.99% |
| operating profit margin | -2979.12% |
| pretax profit margin | -2413.78% |
| net profit margin | -2389.49% |
| return on assets | -100.17% |
| return on equity | -106.9% |
| return on capital employed | -141.51% |
liquidity ratio | |
|---|---|
| current ratio | 2.06 |
| quick ratio | 2.06 |
| cash ratio | 2.04 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 17.04 |
| days of payables outstanding | 97.94 |
| cash conversion cycle | -80.89 |
| receivables turnover | 21.42 |
| payables turnover | 3.73 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | -2,269.05 |
| cash flow to debt ratio | -65.87 |
cash flow ratios | |
|---|---|
| free cash flow per share | -8.34 |
| cash per share | 2.76 |
| operating cash flow per share | -8.34 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -65.87 |
| short term coverage ratios | -422.51 |
| capital expenditure coverage ratio | -2,271,105.20 |
Frequently Asked Questions
When was the last time Bionomics Limited (NASDAQ:BNOX) reported earnings?
Bionomics Limited (BNOX) published its most recent earnings results on 14-11-2024.
What is Bionomics Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Bionomics Limited (NASDAQ:BNOX)'s trailing twelve months ROE is -106.9%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Bionomics Limited (BNOX) currently has a ROA of -100.17%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BNOX's net profit margin stand at?
BNOX reported a profit margin of -2389.49% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BNOX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.06 in the most recent quarter. The quick ratio stood at 2.06, with a Debt/Eq ratio of 0.01.